Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px
Document › Details

Agilent Technologies Inc.. (9/13/12). "Press Release: Agilent Technologies, MRM Proteomics Sign Comarketing Agreement to Further Quantitative Proteomics Technologies". Santa Clara, CA & Vancouver, BC.

Organisation Organisation MRM Proteomics Inc.
Products Product multiple reaction monitoring (MRM) technology
  Product 2 6490 iFunnel Triple Quadrupole LC/MS system (Agilent)
Index term Index term Agilent–MRM Proteomics: proteomics, 201209– collab co-marketing by both of more complete quantitative proteomics solutions
Persons Person Fischer, Steve (Agilent 200806 Product Manager Metabolomics)
  Person 2 Munk, Andrew (MRM Proteomics 201209 CEO)
     


Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a comarketing agreement with MRM Proteomics Inc., a leading provider of advanced protein quantitation, biomarker and proteomic services to the pharmaceutical, biotechnology and diagnostics industries. The agreement will allow both organizations to offer a more complete solution, including kits, hardware and software for proteomics.

Proteomics is the study of the structure and function of proteins and how they interact within a complex biological system. Agilent's integrated proteomics workflow provides the highest analytical performance with unprecedented plug-and-play flexibility. Interchangeable workflows simplify setups and let researchers quickly switch between different methodologies. Offering the industry's highest sensitivity and highest throughput quantitation, the Agilent 6490 Triple Quadrupole MS/MS provides targeted MRM peptide quantitation at attomole detection levels.

"MRM Proteomics, is recognized as a pioneer and leading company in the development of mass spec based methods for protein quantification using multiple reaction monitoring," said Steve Fischer, Agilent marketing manager, Metabolomics and Proteomics. "The agreement is a further reflection of Agilent's continued commitment and investment in quantitative proteomics."

MRM Proteomics specializes in the highly multiplexed absolute quantitation of proteins in complex biological samples such as blood, cerebrospinal fluid and urine through MRM-MS using isotopically labeled internal standards. MRM Proteomics' workflows utilize minimal sample volumes (20 ul) and are capable of unparalleled specificity and sensitivity, without the need for depletion of high-abundance proteins.

"MRM Proteomics is pleased to enter into this comarketing arrangement with Agilent Technologies; our companies' offerings are clearly complementary in the field of targeted quantitative proteomics," said Andrew Munk, chief executive officer of MRM Proteomics. "Mass spectrometry is a rapidly growing platform driving basic proteomics research, biomarker discovery and drug development. Agilent's status as an innovator in mass spec instrumentation combined with its extensive global network, make Agilent a great partner for MRM Proteomics."


About MRM Proteomics

MRM Proteomics is a leader in providing advanced protein quantitation and proteomic services to the pharmaceutical, biotechnology and diagnostics industries in key areas such as biomarker discovery/validation, clinical studies, diagnostics and toxicology. Information about MRM Proteomics is available at www.mrmproteomics.com.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,000 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.

# # #

Contact:

Eric Endicott
+ 1 408 553 2005
eric_endicott@agilent.com

   
Record changed: 2016-03-19

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px